Comparison of biomarkers of oxidative stress, 8-isoprostane,advanced oxidation protein products,and 8-hydroxy-2′-deoxyguanosine and pro-apoptosis,cytokeratin 18 M30, in women with normal glucose tolerance and gestational diabetes mellitus

International Journal of Diabetes in Developing Countries - We aimed to compare the values of selected biomarkers of oxidative stress, 8-isoprostane (8IsoP), advanced oxidation protein products...     

The effect of salmon calcitonin against glutamate-induced cytotoxicity in the C6 cell line and the roles the inflammatory and nitric oxide pathways play

Metabolic Brain Disease - Recent evidence has shown that salmon calcitonin (sCT) has positive effects on the nervous system. However, its effect and mechanisms on glutamate-induced cytotoxicity are...     

The significance of thiol/disulfide homeostasis and ischemia-modified albumin levels to assess the oxidative stress in patients with different stages of diabetes mellitus

This study investigated the value of Thiol/Disulfide homeostasis and ischemia-modified albumin (IMA) levels in discriminating diabetic cases with different stages of retinopathy and without retinopathy. In total, 122 patients with type 2 diabetes mellitus (DM) were enrolled in this prospective cross-sectional study. These patients were separated into three subgroups: Group 1 included 42 patients with DM and no diabetic retinopathy (DR), Group 2 included 40 patients with DM having non-proliferative DR and the Group 3 had 40 patients with DM having proliferative DR. The native thiol, total thiol, and disulfide levels and disulfide–native thiol, disulfide–total thiol, and native thiol–total thiol ratios as well as the IMA levels were analyzed and compared among the groups. There were no statistically significant differences regarding the ages and genders of the patients between the groups. The native thiol level, the total thiol level and the native thiol–total thiol ratio showed a statistically significantly reduction, while the disulfide level, the disulfide–native thiol ratio, and the disulfide–total thiol ratio showed a statistically significantly elevation in the Group 3 compared with the Group 1 and Group 2. Additionally, the mean IMA levels were statistically significantly higher in Group 3 when compared to Group 1 and Group 2 (p?=?.003 and p?=?.014, respectively). In conclusion, both Thiol/Disulfide homeostasis parameters and IMA levels increase with the progression of DR. Thiol/Disuldife homeostasis balance and IMA levels may be used a biomarker to monitor the tissue ischemia in DM and to discriminate the different stages of DR, in the future.     

The micro-shear bond strength of new endodontic tricalcium silicate-based putty: An in vitro study

This study aimed to compare in vitro micro-shear bond strength (μSBS) of three different endodontic tricalcium silicate-based materials in contact with a bulk-fill resin-based composite. Thirty cylindrical resin blocks with a hole in the centre (2 mm in depth and 4 mm in diameter) were manufactured with a 3D printer and divided into three groups (n = 10), depending on the calcium silicate cement used: light curing TheraCal LC (Bisco, Schaumburg, IL, USA), liquid–powder NeoMTA 2 (NuSmile Avalon Biomed, Bradenton, FL, USA) and putty NeoPutty (NuSmile, Houston, TX, USA). Each sample was stored for 24 h at 37°C and 100% humidity. Then, after adhesive placement, the restorative material Filtek bulk-fill (3 M ESPE, St. Paul, MN, USA) was placed over the capping material using cylindrical plastic capsules (2 mm height and 2 mm) and polymerised for 20 s. Specimens were then tested in a universal testing machine for the compression load resulting in the μSBS. The data were compared with the one-way ANOVA (Welch) and the Tamhane test. The mean value was significantly higher in the TheraCal LC group than in the other two groups (p < 0.05). There was no significant difference between NeoMTA 2 and NeoPutty groups (p > 0.05). The majority of failure modes for all groups were cohesive within biomaterial. Using TheraCal LC in the pulp capping procedure can result in higher bond strength values to the tested bulk-fill resin-based composite than NeoMTA 2 and NeoPutty.     

Clinical features of generalized lipodystrophy in Turkey: A cohort analysis

Aim

To describe the Turkish generalized lipodystrophy (GL) cohort with the frequency of each complication and the death rate during the period of the follow-up.

Methods

This study reports on 72 patients with GL (47 families) registered at different centres in Turkey that cover all regions of the country. The mean ± SD follow-up was 86 ± 78 months.

Results

The Kaplan–Meier estimate of the median time to diagnosis of diabetes and/or prediabetes was 16 years. Hyperglycaemia was not controlled in 37 of 45 patients (82.2%) with diabetes. Hypertriglyceridaemia developed in 65 patients (90.3%). The Kaplan–Meier estimate of the median time to diagnosis of hypertriglyceridaemia was 14 years. Hypertriglyceridaemia was severe (≥ 500 mg/dl) in 38 patients (52.8%). Seven (9.7%) patients suffered from pancreatitis. The Kaplan–Meier estimate of the median time to diagnosis of hepatic steatosis was 15 years. Liver disease progressed to cirrhosis in nine patients (12.5%). Liver disease was more severe in congenital lipodystrophy type 2 (CGL2). Proteinuric chronic kidney disease (CKD) developed in 32 patients (44.4%) and cardiac disease in 23 patients (31.9%). Kaplan–Meier estimates of the median time to diagnosis of CKD and cardiac disease were 25 and 45 years, respectively. Females appeared to have a more severe metabolic disease, with an earlier onset of metabolic abnormalities. Ten patients died during the follow-up period. Causes of death were end-stage renal disease, sepsis (because of recurrent intestinal perforations, coronavirus disease, diabetic foot infection and following coronary artery bypass graft surgery), myocardial infarction, heart failure because of dilated cardiomyopathy, stroke, liver complications and angiosarcoma.

Conclusions

Standard treatment approaches have only a limited impact and do not prevent the development of severe metabolic abnormalities and early onset of organ complications in GL.